Description
Aferetica supports transplant centers and hospitals in advancing organ preservation and processing practices.
Through its innovative technologies combining ex situ perfusion and apheresis, Aferetica helps improve graft quality, optimize the use of available organs, and further enhance the safety of the transplant process.
The solutions developed by the company cover the entire value chain:
• Optimized and secure organ transport with PerTravel (Heart-Liver-Kidney-Pancreas)
• Ex situ perfusion and assessment with PerLife – 4°C to 37°C – (Kidney – Liver)
• Ex situ lung processing (Lungs)
• Targeted organ purification with PerSorb.
For hospital teams, this means:
• Better utilization of marginal organs,
• A potential reduction in post-transplant complications,
• Optimization of clinical protocols,
Aferetica positions itself as a technological and clinical partner, capable of supporting hospitals in integrating innovative, scientifically validated solutions tailored to the current challenges of transplantation.
